The U.S. exports $24 billion worth of blood plasma annually, accounting for 2.69% of its total exports. With compensation for plasma donations banned in most countries, America supplies 94% of the global paid plasma market – creating a complex ecosystem where economic necessity often collides with medical demand.
CGTN Global Stringer interviews reveal grassroots realities: Some donors report relying on payments averaging $35–$65 per session, visiting centers up to 104 times yearly. 'People treat this like part-time work,' one donor explained. Critics argue the system disproportionately affects low-income communities, while supporters emphasize its role in producing life-saving therapies.
Here's what you need to know:
– Plasma-derived medicines treat immune disorders, burns, and trauma
– 60+ nations prohibit paid donations over ethical concerns
– US accounts for 0.73 plasma donations per person annually vs global average of 0.03
As bioethics debates intensify, the plasma industry continues expanding, projected to reach $43 billion globally by 2027. The question remains: Can profit and public health coexist in this red gold rush?
Reference(s):
Finding True America: Are U.S. plasma centers pro bono or for-profit?
cgtn.com
